Underberg Sharon E.
SEC CIK 1630353 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IDXX | Idexx Laboratories | EVP, GC, Corp. Sec | 7,138 | — | $3.55M | 16 | 2022-02-14 | 2026-03-03 |
Most active insiders at IDXX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MAZELSKY JONATHAN JAY | Pres, CEO, Dir | — | $15.34M |
| 2 | Hunt Nimrata | EVP | — | $9.53M |
| 3 | FENNELL GEORGE | EVP | — | $7.34M |
| 4 | Erickson Michael G | EVP | — | $3.37M |
| 5 | Kingsley Lawrence D | Dir | — | $1.17M |
| 6 | Vandebroek Sophie V. | Dir | — | $920.3K |
| 7 | Emerson Andrew | EVP, CFO, Treas | — | — |
| 8 | Schreck Michael | EVP | — | — |
| 9 | Johnson Michael Perkins | EVP | — | — |
| 10 | Peacock Karen | Dir | — | — |
| 12 | Underberg Sharon E. | EVP, GC, Corp. Sec | — | — |
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-05 | 2026-03-03 | IDXX | Idexx Laboratories | Underberg Sharon E. | EVP, GC, Corp. Sec | M - OptEx | $505.53 | +197 | 7,138 | +3% | +$99.6K |
| DM | 2026-02-17 | 2026-02-14 | IDXX | Idexx Laboratories | Underberg Sharon E. | EVP, GC, Corp. Sec | M - OptEx | $0.00 | +832 | 7,192 | +13% | $0 |
| D | 2026-02-17 | 2026-02-14 | IDXX | Idexx Laboratories | Underberg Sharon E. | EVP, GC, Corp. Sec | F - Tax | $629.35 | -251 | 6,941 | -3% | -$158.0K |
| DM | 2025-08-12 | 2025-08-08+ | IDXX | Idexx Laboratories | Underberg Sharon E. | EVP, GC, Corp. Sec | M - OptEx | $217.89 | +5,633 | 6,339 | +798% | +$1.23M |
| D | 2025-08-12 | 2025-08-08 | IDXX | Idexx Laboratories | Underberg Sharon E. | EVP, GC, Corp. Sec | S - Sale+OE | $651.60 | -5,450 | 6,156 | -47% | -$3.55M |
| DM | 2025-02-18 | 2025-02-14 | IDXX | Idexx Laboratories | Underberg Sharon E. | EVP, GC, Corp. Sec | A - Grant | $0.00 | +704 | 5,779 | +14% | $0 |
| D | 2025-02-18 | 2025-02-14 | IDXX | Idexx Laboratories | Underberg Sharon E. | EVP, GC, Corp. Sec | F - Tax | $444.53 | -219 | 6,127 | -3% | -$97.4K |
| D | 2024-02-20 | 2024-02-16 | IDXX | Idexx Laboratories | Underberg Sharon E. | EVP, GC, Corp. Sec | M - OptEx | $206.94 | +483 | 5,595 | +9% | +$100.0K |
| DM | 2024-02-16 | 2024-02-14 | IDXX | Idexx Laboratories | Underberg Sharon E. | EVP, GC, Corp. Sec | A - Grant | $0.00 | +1,186 | 5,292 | +29% | $0 |
| D | 2024-02-16 | 2024-02-14 | IDXX | Idexx Laboratories | Underberg Sharon E. | EVP, GC, Corp. Sec | F - Tax | $560.56 | -356 | 5,112 | -7% | -$199.6K |
| D | 2023-05-08 | 2023-05-05 | IDXX | Idexx Laboratories | Underberg Sharon E. | EVP, GC, Corp. Sec | M - OptEx | $206.94 | +483 | 4,245 | +13% | +$100.0K |
| DM | 2023-02-16 | 2023-02-14 | IDXX | Idexx Laboratories | Underberg Sharon E. | EVP, GC, Corp. Sec | M - OptEx | $0.00 | +1,010 | 3,879 | +35% | $0 |
| D | 2023-02-16 | 2023-02-14 | IDXX | Idexx Laboratories | Underberg Sharon E. | EVP, GC, Corp. Sec | F - Tax | $503.65 | -305 | 3,747 | -8% | -$153.6K |
| D | 2022-02-18 | 2022-02-17 | IDXX | Idexx Laboratories | Underberg Sharon E. | EVP, GC, Corp. Sec | M - OptEx | $206.94 | +483 | 2,987 | +19% | +$100.0K |
| DM | 2022-02-16 | 2022-02-14 | IDXX | Idexx Laboratories | Underberg Sharon E. | EVP, GC, Corp. Sec | M - OptEx | $0.00 | +838 | 2,619 | +47% | $0 |
| D | 2022-02-16 | 2022-02-14 | IDXX | Idexx Laboratories | Underberg Sharon E. | EVP, GC, Corp. Sec | F - Tax | $505.53 | -253 | 2,504 | -9% | -$127.9K |
Purchase Sale Sale after option exercise All abbreviations